← FDA Drug Approvals (Drugs@FDA)

XENLETA

NDA · New Drug Application · Sponsor: HONG KONG · Approved 2019-08-19

Drug application

FDA Application #

NDA211673

Application type

New Drug Application

Brand name

XENLETA

Generic name

Lefamulin Acetate

Active ingredients

LEFAMULIN ACETATE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

HONG KONG

First approval

2019-08-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown